# PDS Biotechnology Corp: filings

PDSB · Nasdaq · CIK 1472091 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pdsb.md) · [Financials](/companies/pdsb/financials.md) · [Filings](/companies/pdsb/filings.md) · [Insiders](/companies/pdsb/insiders.md)

## Reports and events: 360 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 280, 4 222, 3 45, 10-Q 33, CORRESP 23, S-8 17, DEF 14A 12, DEFA14A 12, UPLOAD 12, 10-K 11, EFFECT 9, SC 13G/A 9, 424B5 8, 425 7, S-3 7, D 6, SC 13G 6, 4/A 5, 8-K/A 5, DRS/A 5, SC 13D/A 5, ARS 4, CT ORDER 4, DRSLTR 4, S-1/A 4, SC 13D 4, 424B4 3, PRE 14A 3, S-1 3, 10-K/A 2, 424B2 2, 424B3 2, DEFR14A 2, FWP 2, 144 1, 8-A12B 1, CERTNAS 1, D/A 1, DRS 1, S-1MEF 1, S-3/A 1, S-4 1, S-4/A 1, SCHEDULE 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 23:59 ET | [8-K](/filings/0001140361-26-040283.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040283 |
| 2026-10-20 | 12:00 ET | [8-K](/filings/0001140361-26-040181.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-040181 |
| 2026-10-06 | 12:05 ET | [8-K](/filings/0001140361-26-038728.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038728 |
| 2026-09-22 | 12:05 ET | [8-K](/filings/0001140361-26-037298.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-037298 |
| 2026-09-21 | 01:56 ET | [SCHEDULE 13D](/filings/0001193125-26-397073.md) | Ownership report, active investor | 0001193125-26-397073 |
| 2026-09-21 | 20:05 ET | [8-K](/filings/0001140361-26-037234.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-037234 |
| 2026-09-14 | 20:10 ET | [8-K](/filings/0001140361-26-036489.md) | 1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-036489 |
| 2026-09-08 | 12:35 ET | [8-K](/filings/0001140361-26-035853.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-035853 |
| 2026-09-04 | 21:25 ET | [8-K](/filings/0001140361-26-035809.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-035809 |
| 2026-08-25 | 20:08 ET | [8-K](/filings/0001140361-26-034320.md) | 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001140361-26-034320 |
| 2026-08-19 | 20:52 ET | [8-K](/filings/0001140361-26-033749.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-033749 |
| 2026-08-14 | 12:00 ET | [8-K](/filings/0001140361-26-032947.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-032947 |
| 2026-08-13 | 20:20 ET | [10-Q](/filings/0001140361-26-032824.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032824 |
| 2026-08-13 | 12:35 ET | [8-K](/filings/0001140361-26-032650.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032650 |
| 2026-08-11 | 12:30 ET | [8-K](/filings/0001140361-26-032142.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-032142 |
| 2026-07-31 | 20:15 ET | [8-K](/filings/0001140361-26-030497.md) | 3.01 Delisting notice | 0001140361-26-030497 |
| 2026-06-26 | 20:15 ET | [DEF 14A](/filings/0001140361-26-026564.md) | Proxy statement, period 2026-08-10 | 0001140361-26-026564 |
| 2026-06-15 | 20:00 ET | [8-K](/filings/0001140361-26-025207.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001140361-26-025207 |
| 2026-06-15 | 12:00 ET | [8-K](/filings/0001140361-26-025121.md) | 8.01 Other events | 0001140361-26-025121 |
| 2026-06-02 | 19:35 ET | [8-K](/filings/0001140361-26-023698.md) | 8.01 Other events | 0001140361-26-023698 |
| 2026-05-14 | 20:07 ET | [10-Q](/filings/0001140361-26-021286.md) | Quarterly report, period 2026-03-31 | 0001140361-26-021286 |
| 2026-05-13 | 11:05 ET | [8-K](/filings/0001140361-26-020934.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020934 |
| 2026-05-01 | 16:26 ET | [8-K](/filings/0001140361-26-018464.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001140361-26-018464 |
| 2026-04-28 | 20:30 ET | [10-K/A](/filings/0001140361-26-017461.md) | Annual report, amended, period 2025-12-31 | 0001140361-26-017461 |
| 2026-04-24 | 20:05 ET | [8-K](/filings/0001140361-26-016684.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-016684 |
| 2026-04-15 | 12:55 ET | [8-K](/filings/0001140361-26-014693.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-014693 |
| 2026-03-30 | 21:39 ET | [10-K](/filings/0001140361-26-012030.md) | Annual report, period 2025-12-31 | 0001140361-26-012030 |
| 2026-03-30 | 11:05 ET | [8-K](/filings/0001140361-26-011862.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-011862 |
| 2026-03-03 | 17:01 ET | [8-K](/filings/0001140361-26-007478.md) | 3.01 Delisting notice | 0001140361-26-007478 |
| 2026-02-23 | 21:05 ET | [8-K](/filings/0001140361-26-006410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006410 |
| 2026-02-20 | 13:35 ET | [8-K](/filings/0001140361-26-006229.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006229 |
| 2026-01-28 | 13:50 ET | [8-K](/filings/0001140361-26-002608.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-002608 |
| 2026-01-22 | 13:50 ET | [8-K](/filings/0001140361-26-001958.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-001958 |
| 2026-01-09 | 13:50 ET | [8-K](/filings/0001140361-26-000786.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-000786 |
| 2025-12-09 | 13:05 ET | [8-K](/filings/0001140361-25-044940.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-044940 |
| 2025-12-02 | 13:35 ET | [8-K](/filings/0001140361-25-043889.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-043889 |
| 2025-11-13 | 21:08 ET | [10-Q](/filings/0001140361-25-041976.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041976 |
| 2025-11-13 | 12:35 ET | [8-K](/filings/0001140361-25-041805.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041805 |
| 2025-11-12 | 14:12 ET | [8-K](/filings/0001140361-25-041563.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041563 |
| 2025-11-10 | 13:35 ET | [8-K](/filings/0001140361-25-041286.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-041286 |
| 2025-10-29 | 12:45 ET | [8-K](/filings/0001140361-25-039656.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-039656 |
| 2025-09-18 | 12:50 ET | [8-K](/filings/0001140361-25-035339.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035339 |
| 2025-08-25 | 20:06 ET | [8-K](/filings/0001140361-25-032503.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032503 |
| 2025-08-25 | 12:35 ET | [8-K](/filings/0001140361-25-032433.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-032433 |
| 2025-08-13 | 20:35 ET | [10-Q](/filings/0001140361-25-030825.md) | Quarterly report, period 2025-06-30 | 0001140361-25-030825 |
| 2025-08-13 | 11:05 ET | [8-K](/filings/0001140361-25-030701.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030701 |
| 2025-07-10 | 12:05 ET | [8-K](/filings/0001140361-25-025409.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-025409 |
| 2025-06-25 | 20:06 ET | [8-K](/filings/0001140361-25-023644.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023644 |
| 2025-06-11 | 20:37 ET | [8-K](/filings/0001140361-25-022212.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-022212 |
| 2025-06-02 | 12:05 ET | [8-K](/filings/0001140361-25-021032.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-021032 |

Page 1 of 8. [Older](/companies/pdsb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.